EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 143 filers reported holding EPIZYME INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $34,051,000 | +141.8% | 1,384,200 | +1.4% | 6.68% | +31.2% |
| Q3 2019 | $14,080,000 | -17.8% | 1,365,000 | 0.0% | 5.09% | -2.5% |
| Q2 2019 | $17,131,000 | +1.3% | 1,365,000 | 0.0% | 5.22% | +11.5% |
| Q1 2019 | $16,912,000 | +144.0% | 1,365,000 | +21.3% | 4.68% | +81.1% |
| Q4 2018 | $6,930,000 | +226.9% | 1,125,000 | +462.5% | 2.59% | +379.8% |
| Q3 2018 | $2,120,000 | -43.1% | 200,000 | -27.3% | 0.54% | -44.1% |
| Q2 2018 | $3,726,000 | +200.0% | 275,000 | +292.9% | 0.96% | +171.5% |
| Q1 2018 | $1,242,000 | -52.8% | 70,000 | -39.4% | 0.36% | -81.7% |
| Q1 2014 | $2,630,000 | – | 115,500 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |